Clinical Trials Logo

Recurrent or Refractory Medulloblastoma clinical trials

View clinical trials related to Recurrent or Refractory Medulloblastoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01106508 Completed - Clinical trials for Advanced Solid Tumors

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Start date: October 2010
Phase: Phase 1
Study type: Interventional

This first-in-human dose-escalation study is to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of LEQ506 given orally on a daily dosing schedule in patients with advanced solid tumors.